CONNECTs
Our programmes
- See All
- Podcast
- Experts knowledge share
- E-learning
- Video
- Publication
- Other
Episode
1
of 2
-
Downloadable
Resources -
5 MIN
-
Sep 2021
Downloadable 
5 MIN
Sep 2021 
Update from ASCO 2019
LYMPHOMA CONNECT has summarised highlights of the recent ASCO 2019 meeting
Experts
Prof. Paul M Barr-
Downloadable
Resources -
5 MIN
-
Sep 2021
Episode
2
of 2
-
Downloadable
Resources -
5 MIN
-
Sep 2021
Update from ASCO and EHA 2021 on Multiple Myeloma
Dr Hans Lee summarises the latest news in multiple myeloma from the ASCO and EHA 2021 virtual meetings.
Experts
Asst. Prof. Hans Lee-
Downloadable
Resources -
5 MIN
-
Sep 2021
Highlights in Multiple Myeloma
Dr. María-Victoria Mateos discusses Highlights in Multiple Myeloma (MM), focusing on recent developments in the treatment of triple- or penta-refractory MM.
Experts
Assoc. Prof. María Victoria Mateos-
Downloadable
Resources -
5 MIN
-
Sep 2021
Episode
1
of 2
-
Downloadable
Resources -
5 MIN
-
Sep 2021
Episode
2
of 2
-
Downloadable
Resources -
5 MIN
-
Sep 2021
Podcast
Episode
1
of 3
Choosing the Best Treatment Regimen in NDMM
Episode 1: Choosing the Best Treatment Regimen in NDMM
Experts
Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Joshua Richter-
Downloadable
Resources -
MIN
-
Oct 2021
Podcast
Episode
2
of 3
Choosing the Best Treatment Regimen in RRMM
Episode 2: Choosing the Best Treatment Regimen in RRMM
Experts
Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Joshua Richter-
Downloadable
Resources -
MIN
-
Oct 2021
Update from the 2021 Autumn Congresses in Multiple Myeloma
Dr Claudio Cerchione summarises highlights from SOHO, SOHO Italy and IMW 2021
Experts
Dr Claudio Cerchione-
Downloadable
Resources -
10 MIN
-
Nov 2021
Podcast
Episode
3
of 3
Choosing the Best Treatment Regimen in Patients with High-Risk Cytogenetics
Episode 3: Choosing the Best Treatment Regimen in Patients with High-Risk Cytogenetics
Experts
Assoc. Prof. María Victoria Mateos, Dr Alexander M Lesokhin-
Downloadable
Resources -
MIN
-
Mar 2022
Update From ASCO 2022 – Selected LBAs
COR2ED brings you an update on the late breaker plenary sessions from ASCO 2022
Experts
Dr Rebecca Dent, Prof. Chiara Cremolini, Asst. Prof. Hans Lee, Prof. Jonathan Trent-
7 MIN
-
May 2022
Update from ASCO 2022 – Myeloma
Dr Hans Lee summarises the highlights from the phase 3 DETERMINATION trial: Lenalidomide, bortezomib, and dexamethasone (RVd) ± autologous stem cell transplantation (ASCT) and R maintenance to progression for newly diagnosed multiple myeloma (NDMM)
Experts
Asst. Prof. Hans Lee-
2 MIN
-
May 2022
COR2ED at ESMO 2022
We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022. In 10 years, 500,000 healthcare professionals have trusted our educational programmes.
-
2 MIN
-
Sep 2022
Update From ESMO 2022 Presidential Sessions
COR2ED brings you an update on a selection of late-breaking abstracts presented in the Presidential Symposia at ESMO 2022.
Experts
Dr Thomas Winder, Dr Ray Manneh Kopp, Dr Alfredo Addeo-
10 MIN
-
Sep 2022
Update From ASH 2022
Highlights from the ASH Annual Meeting
Experts
Dr Matthew J. Matasar-
4 MIN
-
Dec 2022
Optimising the management of multiple myeloma in the early relapsed/refractory setting (RRMM)
Medical experts discuss the latest learnings from clinical practice
Experts
Prof. Aurore Perrot, Prof. Hermann Einsele, Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Joshua Richter-
Downloadable
Resources -
MIN
-
Jun 2024
Video
Early relapsed/refractory multiple myeloma (RRMM): best practices in management
A 3-part video series on managing early RRMM from leading medical experts
Experts
Assoc. Prof. Elena Zamagni, Dr Fredrik Schjesvold, Dr Joseph Mikhael-
Downloadable
Resources -
4 MIN
-
Sep 2024